Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1996 Jul;103(7):695-701.
doi: 10.1111/j.1471-0528.1996.tb09840.x.

Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour

Affiliations
Free article
Clinical Trial

Randomised comparison between a loading and incremental dose model for ritodrine administration in preterm labour

C A Holleboom et al. Br J Obstet Gynaecol. 1996 Jul.
Free article

Abstract

Objective: To compare a new loading dose regimen for intravenous ritodrine administration in preterm labour with the conventional dose regimen.

Design: Multicentre randomised trial using numbered opaque sealed envelopes.

Setting: Five teaching hospitals in the Netherlands.

Participants: Women (n = 203) in preterm labour at less than 34 weeks of gestation.

Interventions: Women received either a loading dose ritodrine infusion followed, as soon as tocolysis was reached, by a decrease in infusion rate or the conventional schedule of increasing doses until uterine quiescence was achieved.

Results: Frequency of successful tocolysis (71%) and duration of treatment (55 h) were similar in both groups, but the loading dose schedule was better tolerated with fewer adverse events. Also the number of dose adjustments was smaller than in the incremental dose group (P < 0.001). Overall, the differences between the two regimens were unexpectedly small.

Conclusions: Despite the small differences, the loading model is easier to apply, requires fewer dose adjustments, is better tolerated with less side effects, and reduces the likelihood of clinical error.

PubMed Disclaimer

LinkOut - more resources